News

Applications open for the 2026 Gustave Roussy Prize

Inaugurated this year, the Gustave Roussy Prize returns in 2026 to honor a researcher whose scientific discoveries have had a major impact on cancer care. Endowed with €200,000, this prestigious international award recognizes groundbreaking contributions to oncology. 

Published on

Changed on

Gustave Roussy prize 2016

Inaugurated this year, the Gustave Roussy Prize returns in 2026 to honor a researcher whose scientific discoveries have had a major impact on cancer care. Endowed with €200,000, this prestigious international award recognizes groundbreaking contributions to oncology.

Applications are now open and will be accepted until September 4, 2025. The winner will be announced on World Cancer Day, 4 February 2026.

Gustave Roussy prize 2016

A pioneer in oncology, Professor Gustave Roussy revolutionized cancer medicine by establishing dedicated cancer consultation in 1921. Established to commemorate the 150th anniversary of Professor Gustave Roussy birth and the 100th anniversary of the Institute that bears his name, the Gustave Roussy Prize recognizes a leading researcher in oncology, whose scientific discoveries in diagnosis, treatment or prevention, have led to significant improvements in patient care or understanding of the disease.

This prize celebrates scientific excellence and patient-centered innovation in line with Gustave Roussy's mission: to cure people more effectively.

The €200,000 prize is one of the most generous global awards dedicated to fight against cancer.

Application deadline: 4 September 2025, 4pm (CEST)

Researchers of all nationalities are invited to submit an application by September 4, 2025, 4pm (CEST), via the online form: application deadline

Applications will be reviewed by an independent jury of international experts, based on criteria of scientific excellence and clinical impact, without distinction of discipline or institutional affiliation.

The Gustave Roussy Prize is awarded annually by Fondation Gustave Roussy , with the generous support of Pierre Fabre Laboratories, founding sponsor.

More about :

► The inaugural edition of the Gustave Roussy Prize awarded to Professor Charles Swanton

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin